Rein Therapeutics, Inc. (RNTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2021 | $157.0K | +3040.0% |
| 2020 | $5.0K | -96.7% |
| 2019 | $151.0K | -96.6% |
| 2018 | $4.42M | +3014.8% |
| 2017 | $142.0K | — |
| 2015 | $94.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2021 | $157.0K | +3040.0% |
| 2020 | $5.0K | -96.7% |
| 2019 | $151.0K | -96.6% |
| 2018 | $4.42M | +3014.8% |
| 2017 | $142.0K | — |
| 2015 | $94.0K | — |